ArticleScientific reports2024

Analytical performance validation of aPROMISE platform for prostate tumor burden, index and dominant tumor assessment with 18F-DCFPyL PET/CT. A pilot study.

Ana María García Vicente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.